PharmaLearnNet's profile picture. Your Go-To Resource for Clinical and Regulatory Updates for Pharmacy Professionals
@PopHealthNet

Pharmacy Learning Network

@PharmaLearnNet

Your Go-To Resource for Clinical and Regulatory Updates for Pharmacy Professionals @PopHealthNet

Dr Jennings shares findings from a new study evaluating RAAS inhibitors for the treatment of advanced chronic kidney disease. buff.ly/3iiUHxp

PharmaLearnNet's tweet image. Dr Jennings shares findings from a new study evaluating RAAS inhibitors for the treatment of advanced chronic kidney disease. buff.ly/3iiUHxp

A Class II #recall has been issued for a #prescription #Medication used to reverse the effects of nondepolarizing neuromuscular blocking agents after surgery. buff.ly/3uc8usn

PharmaLearnNet's tweet image. A Class II #recall has been issued for a #prescription #Medication used to reverse the effects of nondepolarizing neuromuscular blocking agents after surgery. buff.ly/3uc8usn

A prescription #drug used to manage hypertension is being recalled due to potential cross contamination. buff.ly/3EVlaZw

PharmaLearnNet's tweet image. A prescription #drug used to manage hypertension is being recalled due to potential cross contamination. buff.ly/3EVlaZw

Several lots of hand sanitizer are being recalled after the US Food and Drug Administration found undeclared methanol in one. buff.ly/3EPe2xL

PharmaLearnNet's tweet image. Several lots of hand sanitizer are being recalled after the US Food and Drug Administration found undeclared methanol in one. buff.ly/3EPe2xL

Nicole L Stout, DPT, CLT-LANA, FAPTA, shares her team’s research on distress screening and a quality improvement project to boost provider efficiency and close gaps in patients’ cancer #care buff.ly/3gFQ0xp

PharmaLearnNet's tweet image. Nicole L Stout, DPT, CLT-LANA, FAPTA, shares her team’s research on distress screening and a quality improvement project to boost provider efficiency and close gaps in patients’ cancer #care 
buff.ly/3gFQ0xp

Our readership reported staffing and scheduling issues as the leading cause of burnout among pharmacists. What actions, if any, has your organization taken to address burnout? buff.ly/3Uihjve

PharmaLearnNet's tweet image. Our readership reported staffing and scheduling issues as the leading cause of burnout among pharmacists. What actions, if any, has your organization taken to address burnout?  buff.ly/3Uihjve

Check out our #quiz and test your knowledge on the recommended dosage of an H2 blocker for gastroesophageal reflux disease. buff.ly/3VwlQeH

PharmaLearnNet's tweet image. Check out our #quiz and test your knowledge on the recommended dosage of an H2 blocker for gastroesophageal reflux disease. buff.ly/3VwlQeH

Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the #Omicron subvariants BQ.1 and BQ.1.1. buff.ly/3V12j65

PharmaLearnNet's tweet image. Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the #Omicron subvariants BQ.1 and BQ.1.1. buff.ly/3V12j65

In the second part of his coverage of AHA Scientific Sessions 2022, Dr Jennings shares 2 randomized trials designed to compare diuretics for the treatment of hypertension and #HeartFailure buff.ly/3gdpzil

PharmaLearnNet's tweet image. In the second part of his coverage of AHA Scientific Sessions 2022, Dr Jennings shares 2 randomized trials designed to compare diuretics for the treatment of hypertension and #HeartFailure 
buff.ly/3gdpzil

In the latest issue of Talking Therapeutics, Dr Jennings highlights #data from American Heart Association Scientific Sessions 2022, including research into direct oral anticoagulants, a novel fibrate, and more. buff.ly/3Ut9yDH

PharmaLearnNet's tweet image. In the latest issue of Talking Therapeutics, Dr Jennings highlights #data from American Heart Association Scientific Sessions 2022, including research into direct oral anticoagulants, a novel fibrate, and more. buff.ly/3Ut9yDH

Dr Jennings discusses the potential of xenotransplantation, the transplant of nonhuman tissues and organs into a human recipient, for alleviating organ scarcity across the world. buff.ly/3fQ5sGy

PharmaLearnNet's tweet image. Dr Jennings discusses the potential of xenotransplantation, the transplant of nonhuman tissues and organs into a human recipient, for alleviating organ scarcity across the world. buff.ly/3fQ5sGy

A Class I #Recall has been issued for atenolol tablets due to a bottle mistakenly containing clopidogrel. buff.ly/3Wx1zH9

PharmaLearnNet's tweet image. A Class I #Recall has been issued for atenolol tablets due to a bottle mistakenly containing clopidogrel. buff.ly/3Wx1zH9

Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending #trends that emerged over the course of 2021 and predicts how spending will continue to change. buff.ly/3fHbpWd

PharmaLearnNet's tweet image. Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending #trends that emerged over the course of 2021 and predicts how spending will continue to change. buff.ly/3fHbpWd

In the latest installment of Talking Therapeutics, Dr Jennings shares a randomized study in which patients with mild to moderate cases of #COVID19 were treated with either ivermectin or placebo. buff.ly/3flnZdH

PharmaLearnNet's tweet image. In the latest installment of Talking Therapeutics, Dr Jennings shares a randomized study in which patients with mild to moderate cases of #COVID19 were treated with either ivermectin or placebo. buff.ly/3flnZdH

Social determinants of health, such as location and household income, influenced American Indian and Alaska Native individuals' use of clinical #pharmacy services. buff.ly/3DaskIO

PharmaLearnNet's tweet image. Social determinants of health, such as location and household income, influenced American Indian and Alaska Native individuals' use of clinical #pharmacy services. buff.ly/3DaskIO

Want to stay up-to-date on all the featured content from our trusted brands? Follow their respective pages, designed to curate the latest clinical insights, industry news, conference coverage, and more with thought leaders in #PopulationHealth and more! buff.ly/35pWM0Q

PharmaLearnNet's tweet image. Want to stay up-to-date on all the featured content from our trusted brands? Follow their respective pages, designed to curate the latest clinical insights, industry news, conference coverage, and more with thought leaders in #PopulationHealth and more!  buff.ly/35pWM0Q

Tracing reports by pharmacists resulted in cost savings by reducing leftover medications and prompting #Pharmaceutical interventions for #patientsafety. buff.ly/3VIdnWG

PharmaLearnNet's tweet image. Tracing reports by pharmacists resulted in cost savings by reducing leftover medications and prompting #Pharmaceutical interventions for #patientsafety. buff.ly/3VIdnWG

Dr Jennings shares a new study which suggests lower doses of guideline-directed medical therapy might still produce a significant benefit for patients. buff.ly/3eQOR58

PharmaLearnNet's tweet image. Dr Jennings shares a new study which suggests lower doses of guideline-directed medical therapy might still produce a significant benefit for patients. buff.ly/3eQOR58

A Class II #recall has been issued for 103,150 vials of a #prescription bronchodilator following the report of a hair found in a vial. buff.ly/3yMsDIk

PharmaLearnNet's tweet image. A Class II #recall has been issued for 103,150 vials of a #prescription bronchodilator following the report of a hair found in a vial. buff.ly/3yMsDIk

In a session at #AMCPNexus 2022, speakers discussed the rise in #stimulant #overdoses with an emphasis on treatment options and how providers and health plans can better manage patients with stimulant use disorder. buff.ly/3yOl1ou

PharmaLearnNet's tweet image. In a session at #AMCPNexus 2022, speakers discussed the rise in #stimulant #overdoses with an emphasis on treatment options and how providers and health plans can better manage patients with stimulant use disorder. buff.ly/3yOl1ou

Loading...

Something went wrong.


Something went wrong.